HAZI Trademark

Trademark Overview


On Tuesday, January 3, 2023, a trademark application was filed for HAZI with the United States Patent and Trademark Office. The USPTO has given the HAZI trademark a serial number of 79361881. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 27, 2024. This trademark is owned by MEPRO MEDICAL REPRODUCTIVE SOLUTIONS, S.L.. The HAZI trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Chemical reagents with biomarkers for medical diagnostics; Chemical reagents for in-vitro use in laboratories for medical purposes; In-vitro diagnostic preparations for medical use; fertility enhancement preparations; products for medical diagnostics, namely, medical diagnostic test reagents for use in the field of infertility, namely, male infertility; diagnostic preparations for medical purposes; products for use in human and animal assisted-reproduction treatments, namely, diagnostic preparations for medical and veterinary use

Physiological apparatus for medical use, namely, apparatus for selecting spermatozoa for improving assisted reproductive treatment; medical instruments for reproducing physiological data, namely, displaying sperm motility ability and sperm fertilization capacity; medical instruments for recording physiological data, namely, monitoring sperm motility ability and sperm fertilization capacity; equipment for diagnosis, examination and monitoring, namely, equipment for monitoring sperm motility ability and sperm fertilization capacity; instruments for medical diagnosis, namely, instruments for monitoring and selecting spermatozoa with greatest fertilizing capacity
hazi

General Information


Serial Number79361881
Word MarkHAZI
Filing DateTuesday, January 3, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Goods and ServicesChemical reagents with biomarkers for medical diagnostics; Chemical reagents for in-vitro use in laboratories for medical purposes; In-vitro diagnostic preparations for medical use; fertility enhancement preparations; products for medical diagnostics, namely, medical diagnostic test reagents for use in the field of infertility, namely, male infertility; diagnostic preparations for medical purposes; products for use in human and animal assisted-reproduction treatments, namely, diagnostic preparations for medical and veterinary use
Goods and ServicesPhysiological apparatus for medical use, namely, apparatus for selecting spermatozoa for improving assisted reproductive treatment; medical instruments for reproducing physiological data, namely, displaying sperm motility ability and sperm fertilization capacity; medical instruments for recording physiological data, namely, monitoring sperm motility ability and sperm fertilization capacity; equipment for diagnosis, examination and monitoring, namely, equipment for monitoring sperm motility ability and sperm fertilization capacity; instruments for medical diagnosis, namely, instruments for monitoring and selecting spermatozoa with greatest fertilizing capacity

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 6, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMEPRO MEDICAL REPRODUCTIVE SOLUTIONS, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameMEPRO MEDICAL REPRODUCTIVE SOLUTIONS, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Friday, February 10, 2023APPLICATION FILING RECEIPT MAILED
Friday, September 29, 2023NON-FINAL ACTION WRITTEN
Saturday, September 30, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 17, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 3, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 27, 2023ASSIGNED TO EXAMINER
Tuesday, October 17, 2023REFUSAL PROCESSED BY MPU
Tuesday, November 7, 2023REFUSAL PROCESSED BY IB
Wednesday, April 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2024NON-FINAL ACTION WRITTEN
Monday, June 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 12, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, July 12, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, July 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024NON-FINAL ACTION E-MAILED